1CellBio and Partek Partner to Launch inDrop Single-Cell Analysis System Integrated with Partek Flow

VCBeat (WeChat Official Account: vcbeat) has learned that single-cell analysis giant 1 Cellbio and leading bioinformatics software company Partek jointly launched the inDrop data analysis pipeline yesterday, which runs seamlessly within the Partek Flow bioinformatics software.

This system enables users to preprocess raw inDrop single-cell RNA-Seq data and leverage Partek’s advanced statistical software and visualization tools to characterize and analyze individual cells. Furthermore, users capable of developing custom inDrop applications can utilize the various single-cell bioinformatics tools provided within the software and configure them through an intuitive interface.

Partek’s single-cell RNA-Seq system is revolutionizing the study of complex tissues and diseases. Its visualization capabilities and user-friendly analytical tools enable researchers to analyze their own single-cell RNA-Seq data. First, the system interface employs interactive plots for barcode and cell filtering, guiding users through subsequent selection steps. Second, it automatically overlays clustering results, gene and pathway expression profiles, and sample attributes onto 3D t-SNE plots to facilitate cell classification. Finally, the system automatically identifies differentially expressed genes and pathways between cell types or treatment conditions, effectively saving researchers time and effort.

Partek Flow Features Page

Single-cell analysis is gaining increasing popularity in the life sciences community, offering novel insights for bioengineering and disease treatment. It can be applied to a wide range of applications, including tumor analysis, drug target validation, identification of intercellular variability, and lineage tracing. However, bioinformatics analysis remains a significant challenge for many researchers, as existing traditional solutions fail to meet the ever-evolving demands of research and applications. To achieve breakthroughs, the biological research community needs to leverage advanced computational technologies and robust internal informatics capabilities to address the limitations of conventional approaches.

Now, Partek Flow addresses this issue by enabling scientists to easily analyze their scRNA-Seq data through an intuitive point-and-click interface.

When asked about the partnership, Tom Downey, President of Partek, stated, “The significance of our collaboration with 1CellBio lies in providing an affordable and user-friendly solution for single-cell data analysis, enabling scientists to address their own research questions without needing to learn or employ overly specialized computational techniques.”

Dr. Colin J.H. Brenan, CEO of CellBio, stated, “They not only provide top-tier scRNA-seq analysis solutions, but also continuously innovate existing technologies to meet our needs as we introduce more single-cell applications.”

Headquartered in St. Louis, Missouri, Partek is a company that develops and analyzes software and technical services for the life sciences sector. Its products hold a leading position across all next-generation sequencing and microarray platforms, with over 7,000 peer-reviewed scientific papers utilizing Partek software to streamline genomic research analysis. Partek has made indispensable contributions to advancing life sciences research.

1CellBio is a globally leading single-cell analysis company deeply engaged in biomedical research. Founded by top scientists from Harvard University, 1CellBio is headquartered in Cambridge, Massachusetts.

1. CellBio’s flagship product, the inDrop™ system, is a high-resolution single-cell transcriptomics platform that is unparalleled in the industry. Research laboratories worldwide are currently adopting this platform for a wide range of single-cell applications, spanning from tumor analysis to stem cell research, and from embryonic development to the identification and validation of new drug targets.